skip to main content

Our response to the Covid-19 outbreak.

Two Tropical Diseases Now Eligible for FDA Priority Review

Peter Hotez, fellow in disease and poverty, comments on the addition of two diseseases to the list of treatments for tropical diseases eligible for FDA priority review. Access by subscription only.